HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Short-term effect of IL-6 inhibition in spondylarthritis.

AuthorsDaniel Wendling, Marie Bossert, Clément Prati
JournalJoint bone spine (Joint Bone Spine) Vol. 77 Issue 6 Pg. 624-5 (Dec 2010) ISSN: 1778-7254 [Electronic] France
PMID20971669 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • IL6 protein, human
  • Interleukin-6
  • C-Reactive Protein
  • tocilizumab
Topics
  • Adult
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents (therapeutic use)
  • C-Reactive Protein (analysis)
  • Disability Evaluation
  • Humans
  • Interleukin-6 (antagonists & inhibitors)
  • Magnetic Resonance Imaging
  • Male
  • Recovery of Function
  • Severity of Illness Index
  • Spondylarthritis (drug therapy, pathology, physiopathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: